Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.
- DOI
- 10.1200/jco.18.01265
- Published
- 2019 Jun 10
- Container
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jco.18.01265,
title = {Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.},
author = {Chung HC and Ros W and Delord JP and Perets R and Italiano A and Shapira-Frommer R and Manzuk L and Piha-Paul SA and Xu L and Zeigenfuss S and Pruitt SK and Leary A},
year = {2019},
journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
doi = {10.1200/jco.18.01265},
url = {https://doi.org/10.1200/jco.18.01265}
}RIS
TY - JOUR TI - Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study. AU - Chung HC AU - Ros W AU - Delord JP AU - Perets R AU - Italiano A AU - Shapira-Frommer R AU - Manzuk L AU - Piha-Paul SA AU - Xu L AU - Zeigenfuss S AU - Pruitt SK AU - Leary A PY - 2019 JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology DO - 10.1200/jco.18.01265 UR - https://doi.org/10.1200/jco.18.01265 ER -
APA
HC, C., W, R., JP, D., R, P., A, I., R, S., L, M., SA, P., L, X., S, Z., SK, P., & A, L. (2019). Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.18.01265
Source records
- pubmed · retrieved 2026-09-25T13:13:22.930Z